Following U.S. and EU market authorization for Waskyra™, AGC Biologics will continue to support the commercial development of the gene therapy.
Morning Overview on MSN
These 'blindness' genes were once a 100% curse, and scientists were wrong
For decades, a genetic test that turned up a mutation linked to inherited blindness was treated as a verdict, not a risk ...
Inflammation has to fight pathogens fast—but it can't get out of control. Researchers at the German Cancer Research Center ...
The company made an even more dramatic claim the following month, when it announced it had created three dire wolves. These ...
Researchers from Carnegie Mellon University have discovered a way to target RNA that could lead to new treatment options for myotonic dystrophy type 1 (DM1), the most common adult-onset form of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback